Enhanced platelet activation in patients with atopic eczema/dermatitis syndrome

Inflammation

Volumn 28, Issue 5, 2004, Pages 299-302

  Kasperska Zaja̧c, Alicja ^a   Nowakowski, Marek ^a   Rogala, Barbara ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Atopic eczema dermatitis syndrome; Beta thromboglobulin; Platelet activation; Platelet factor 4

Indexed keywords

ALPHA CHEMOKINE; BETA THROMBOGLOBULIN; BIOLOGICAL MARKER; IMMUNOGLOBULIN E; THROMBOCYTE FACTOR 4;

ADULT; ARTICLE; ATOPIC DERMATITIS; BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MALE; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE ACTIVATION;

ADOLESCENT; ADULT; BETA-THROMBOGLOBULIN; BLOOD PLATELETS; DERMATITIS, ATOPIC; ECZEMA; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; PLATELET ACTIVATION; PLATELET FACTOR 4; SYNDROME;

EID: 23944434690     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-004-6054-z     Document Type: Article

References (26)

1. Capron, A., J. C. Ameisen, M. Joseph, C. Auriault, A. B. Tonnel, and J. Caen. 1985. New functions for platelets and their pathological implications. Int. Arch. Allergy Appl. Immunol. 77:107-114.
2. Cines, D. B., H. van der Keyl, and A. I. Levinson. 1986. In vitro binding of an IgE protein to human platelets. J. Immunol. 139:3433-3436.
3. Orchard, M. A., A. Kagey-Sobotka, D. Proud, and L. M. Lichtenstein. 1986. Basophil histamine release induced by a substance from stimulated human platelets. J. Immunol. 136:2240-2244.
4. Hayashi, N., J. Chihara, Y. Kobayashi, T. Kakazu, D. Kurachi, T. Yamamoto, and S. Nakajima. 1994. Effect of platelet-activating factor and platelet factor 4 on eosinophil adhesion. Int. Arch. Allergy Immunol. 104(Suppl):57-59.
5. Burgers, J. A., R. C. Schweizer, L. Koenderman, P. L. Bruijnzeel, and J. W. Akkerman. 1993. Human platelets secrete chemotactic activity for eosinophils. Blood 81:49-55.
6. Kaplan, K. L., and J. Owen. 1981. Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 57:199-202.
7. Watanabe, O., K. Natori, M. Tamari, Y. Shiomoto, S. Kubo, and Y. Nakamura. 1999. Significantly elevated expression of PF4 (platelet factor 4) and eotaxin in the NOA mouse, a model for atopic dermatitis. J. Hum. Genet. 44:173-176.
8. Kasperska-Zajac, A., B. Rogala, M. Nowakowski. 2003. Enhanced release of platelet factor 4 into the circulation in patients with the atopic eczema/dermatitis syndrome. Ann. Acad. Med. Bialostocensis. 48:128-130.
9. Hanifin, J., and G. Rajka. 1980. Diagnostic features of atopic dermatitis. Acta. Derm. Venereol. (Stockh.). 92(Suppl):44-47.
10. Rajka, G., and T. Lageland. 1989. Grading of the severity of atopic dermatitis. Acta Derm. Venereol. (Stockh.). 144(Suppl):13-14.
11. Kurihara, Y., H. Nakayama, and S. Nakagawa. 1980. Plasma beta-thromboglobulin and platelet factor 4 in renal insufficiency. Thromb. Res. 18:557-560.
12. Szczeklik, A., P. C. Milner, J. Birch, J. Watkins, and J. F. Martin. 1986. Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever. Thromb. Haemost. 56:283-287.
13. Gallagher, J. S., I. L. Bernstein, C. A. Maccia, G. L. Splansky, and H. I. Glueck. 1978. Cyclic platelet dysfunction in IgE-mediated allergy. J. Allergy Clin. Immunol. 62:229-235.
14. Rogala, B., J. Gumprecht, R. Gawlik, and K. Strojek. 1995. Platelet aggregation in IgE-mediated allergy with elevated soluble FcεRII/CD23 level. J. Invest. Allergol. Clin. Immunol. 5:161-165.
15. Pitchford, S. C., H. Yano, R. Lever, Y. Riffo-Vasquez, S. Ciferri, M. J. Rose, S. Giannini, S. Momi, D. Spina, B. O'Connor, P. Gresele, and C. P. Page. 2003. Platelets are essential for leukocyte recruitment in allergic inflammation. J. Allergy Clin. Immunol. 112:109-118.
16. Rogala, B., J. Gumprecht, and J. Glück. 1999. Platelet aggregation in atopic dermatitis. Platelets. 10:341-344.
17. Hilger, R. A., K. Neuber, and W. Konig. 1991. Conversion of leukotriene A4 by neutrophils and platelets from patients with atopic dermatitis. Immunology 74:689-695.
18. Neuber, K., R. A. Hilger, and W. König. 1992. Differential increase in 12-HETE release and CD29/CD49f expression of platelets from normal donors and from patients with atopic dermatitis. Int. Arch. Allergy Immunol. 98:339-342.
19. Elsner, J., and A. Kapp. 2000. Modulation of eosinophil effector function: The potential role for monoclonal antibodies and chemokine receptor antagonists. Allergy Asthma Proc. 21:345-349.
20. Bruijnzeel, P. L. B., P. H. M. Kuijper, S. Rihs, S. Betz, R. A. J. Warringa, and L. Koenderman. 1993. Eosinophil migration in atopic dermatitis. I: Increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet activating factor, and platelet factor 4. J. Invest. Dermatol. 100:137-142.
21. Cahill, M. R., and A. C. Newland. 1993. Platelet activation in coronary artery disease. Br. J. Biomed Sci. 50:221-234.
22. Sowers, J. R., and M. Epstein. 1995. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update. Hypertension 26:869-879.
23. De Sousa, J. R., M. C. Santos, M. L. Carlos, and A. G. Carlos. 1992. Platelet reactivity to 'in vitro' allergen challenge in asthmatic patients. Allergol. Immunopathol. 20:13-16.
24. Averill, F. J., W. C. Hubbard, D. Proud, G. J. Gleich, and M. C. Liu. 1992. Platelet activation in the lung after antigen challenge in a model of asthma. Am. Rev. Respir. Dis. 145:571-576.
25. Yamamoto, H., M. Nagata, K. Tabe, I. Kimura, H. Kiuchi, Y. Sakamoto, K. Yamamoto, and Y. Dohi. 1993. The evidence of platelet activation in bronchial asthma. J. Allergy Clin. Immunol. 91:79-87.
26. Kasperska-Zajac, A., and B. Rogala. 2003. Platelet activity measured by plasma levels of beta-thromboglobulin and platelet factor 4 in seasonal allergic rhinitis during natural pollen exposure. Inflam. Res. 52:477-479.